对子宫内膜癌的新疗法目标:对临床前领域的一
Ilan Bruchim1,2,3, Ilaria Capasso4,5, Ariel Polonsky1,2
1Gynecology and Gynecologic Oncology Department, Hillel Yaffe Medical Center, Hadera, Israel.
Expert opinion on therapeutic targets
|February 8, 2024
概括
精准医学通过识别四种分子亚型,彻底改变了子宫内膜癌 (EC) 治疗. 分子分析指导量身定制的疗法和风险分类,以改善早期和晚期患者的治疗结果.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子病理学分子病理学
- 精准医学是一门精准的医学.
背景情况:
- 子宫内膜癌 (EC) 是唯一一个患病率和死亡率上升的妇科恶性瘤.
- 标准治疗对于早期的EC是有效的,但精准医学已经改变了管理.
- 最近的基因组测序发现了四种不同的EC分子亚型.
研究的目的:
- 审查目前关于EC分子分析的证据,以对风险进行分类和预测.
- 为早期和高级/转移性EC提供量身定制和向治疗的指导.
- 根据分子分类,提供对最佳外科管理和未来战略的见解.
主要方法:
- 关于子宫内膜癌分子分析的最新证据的综合文献综述.
- 分子子类型的分析,风险分类和预测.
- 量身定制和向治疗方法的评估,包括免疫检查点抑制剂.
主要成果:
- 分子分析可以根据特定突变 (例如,POLE,p53) 量身定制辅助治疗,升级或降级疗法.
- 分子特征促进了新型向疗法的使用,特别是免疫检查点抑制剂,改善了预后.
- 目前正在进行的研究正在探索进一步的分层和治疗选择,以提高精度.
结论:
- 分子分类对于个性化的子宫内膜癌管理至关重要.
- 基于分子亚型的量身定制治疗提供了改善的瘤治疗结果.
- 对分子分层和新型治疗方法的持续研究将进一步完善EC管理.
更多相关视频
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
1.3K
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K